Furthermore, TYMP1 has also been described to possess an anti-apoptotic effect [54,57], whereas IL1RN has been described as an anti-inflammatory antagonist of the interleukin-1 family of proinflammatory cytokines protecting against immune dysregulation and uncontrolled systemic inflammation [58]. Here, IL1RN is linked to inflammation.